Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 101

    1.

    HIV-2 Protease resistance defined in yeast cells.

    M'Barek NB, Audoly G, Raoult D, Gluschankof P.

    Retrovirology. 2006 Sep 6;3:58.

    PMID:
    16956392
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    2.

    Lopinavir/ritonavir: a review of its use in the management of HIV infection.

    Cvetkovic RS, Goa KL.

    Drugs. 2003;63(8):769-802. Review.

    PMID:
    12662125
    [PubMed - indexed for MEDLINE]
    3.

    Mutational patterns and correlated amino acid substitutions in the HIV-1 protease after virological failure to nelfinavir- and lopinavir/ritonavir-based treatments.

    Garriga C, Pérez-Elías MJ, Delgado R, Ruiz L, Nájera R, Pumarola T, Alonso-Socas Mdel M, García-Bujalance S, Menéndez-Arias L; Spanish Group for the Study of Antiretroviral Drug Resistance.

    J Med Virol. 2007 Nov;79(11):1617-28.

    PMID:
    17854027
    [PubMed - indexed for MEDLINE]
    4.

    The influence of protease inhibitor resistance profiles on selection of HIV therapy in treatment-naive patients.

    Turner D, Schapiro JM, Brenner BG, Wainberg MA.

    Antivir Ther. 2004 Jun;9(3):301-14. Review.

    PMID:
    15259893
    [PubMed - indexed for MEDLINE]
    5.

    Susceptibility to protease inhibitors in HIV-2 primary isolates from patients failing antiretroviral therapy.

    Rodés B, Sheldon J, Toro C, Jiménez V, Alvarez MA, Soriano V.

    J Antimicrob Chemother. 2006 Apr;57(4):709-13. Epub 2006 Feb 7.

    PMID:
    16464891
    [PubMed - indexed for MEDLINE]
    Free Article
    7.

    Natural polymorphisms in the human immunodeficiency virus type 2 protease can accelerate time to development of resistance to protease inhibitors.

    Ntemgwa M, Brenner BG, Oliveira M, Moisi D, Wainberg MA.

    Antimicrob Agents Chemother. 2007 Feb;51(2):604-10. Epub 2006 Nov 20.

    PMID:
    17116674
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    8.

    Polymorphism of the human immunodeficiency virus type 2 (HIV-2) protease gene and selection of drug resistance mutations in HIV-2-infected patients treated with protease inhibitors.

    Damond F, Brun-Vezinet F, Matheron S, Peytavin G, Campa P, Pueyo S, Mammano F, Lastere S, Farfara I, Simon F, Chene G, Descamps D.

    J Clin Microbiol. 2005 Jan;43(1):484-7.

    PMID:
    15635022
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    9.

    Response of feline immunodeficiency virus (FIV) to tipranavir may provide new clues for development of broad-based inhibitors of retroviral proteases acting on drug-resistant HIV-1.

    Norelli S, El Daker S, D'Ostilio D, Mele F, Mancini F, Taglia F, Ruggieri A, Ciccozzi M, Cauda R, Ciervo A, Barreca ML, Pistello M, Bendinelli M, Savarino A.

    Curr HIV Res. 2008 Jun;6(4):306-17.

    PMID:
    18691029
    [PubMed - indexed for MEDLINE]
    10.

    Factors associated with the selection of mutations conferring resistance to protease inhibitors (PIs) in PI-experienced patients displaying treatment failure on darunavir.

    Lambert-Niclot S, Flandre P, Canestri A, Peytavin G, Blanc C, Agher R, Soulié C, Wirden M, Katlama C, Calvez V, Marcelin AG.

    Antimicrob Agents Chemother. 2008 Feb;52(2):491-6. Epub 2007 Nov 26.

    PMID:
    18039922
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    12.

    Sequence analysis of the HIV-1 protease coding region of 18 HIV-1-infected patients prior to HAART and possible implications on HAART.

    Gehringer H, Bogner JR, Goebel FD, Nitschko H, von der Helm K.

    J Clin Virol. 2000 Aug;17(2):137-41.

    PMID:
    10942094
    [PubMed - indexed for MEDLINE]
    13.

    In vitro resistance profile of the human immunodeficiency virus type 1 protease inhibitor BMS-232632.

    Gong YF, Robinson BS, Rose RE, Deminie C, Spicer TP, Stock D, Colonno RJ, Lin PF.

    Antimicrob Agents Chemother. 2000 Sep;44(9):2319-26.

    PMID:
    10952574
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    14.

    Development and significance of resistance to protease inhibitors in HIV-1-infected adults under triple-drug therapy in clinical practice.

    Romano L, Venturi G, Giomi S, Pippi L, Valensin PE, Zazzi M.

    J Med Virol. 2002 Feb;66(2):143-50.

    PMID:
    11782921
    [PubMed - indexed for MEDLINE]
    15.

    A novel substrate-based HIV-1 protease inhibitor drug resistance mechanism.

    Nijhuis M, van Maarseveen NM, Lastere S, Schipper P, Coakley E, Glass B, Rovenska M, de Jong D, Chappey C, Goedegebuure IW, Heilek-Snyder G, Dulude D, Cammack N, Brakier-Gingras L, Konvalinka J, Parkin N, Kräusslich HG, Brun-Vezinet F, Boucher CA.

    PLoS Med. 2007 Jan;4(1):e36.

    PMID:
    17227139
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    16.

    Non-infectious fluorimetric assay for phenotyping of drug-resistant HIV proteinase mutants.

    Majerová-Uhlíková T, Dantuma NP, Lindsten K, Masucci MG, Konvalinka J.

    J Clin Virol. 2006 May;36(1):50-9. Epub 2006 Mar 9.

    PMID:
    16527535
    [PubMed - indexed for MEDLINE]
    18.

    Natural residues versus antiretroviral drug-selected mutations in HIV type 1 group O reverse transcriptase and protease related to virological drug failure in vivo.

    de Baar MP, Janssens W, de Ronde A, Fransen K, Colebunders R, Kestens L, van der Groen G, Goudsmit J.

    AIDS Res Hum Retroviruses. 2000 Sep 20;16(14):1385-94.

    PMID:
    11018858
    [PubMed - indexed for MEDLINE]
    19.

    Rapid assessment of phenotypic resistance to protease inhibitors in human immunodeficiency virus type 1 group O.

    Rodés B, Poveda E, Soriano V.

    J Clin Microbiol. 2002 Nov;40(11):4313-6. Erratum in: J Clin Microbiol. 2003 Jan;41(1):527..

    PMID:
    12409418
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    20.

    Clinical cross-resistance between the HIV-1 protease inhibitors saquinavir and indinavir and correlations with genotypic mutations.

    Schapiro JM, Winters MA, Lawrence J, Merigan TC.

    AIDS. 1999 Feb 25;13(3):359-65.

    PMID:
    10199226
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk